DANIELA GARCIA: Open Payments
NPI 1669833612 · MISSION, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$473 in 9 payments from 7 companies in 2025. Trend: 2023 $995 · 2024 $230 · 2025 $473
Food & beverage: $473
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $156 |
| Dexcom, Inc. | 1 | $116 |
| Sage Therapeutics, LLC | 1 | $100 |
| Novo Nordisk Inc | 2 | $38 |
| PFIZER INC. | 1 | $27 |
| Exact Sciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $14 |
Products named: Dexcom G6 Transmitter, LOKELMA, FARXIGA, ELIQUIS, Wegovy, Cologuard Collection Kit, JARDIANCE, Ozempic.
Industry payments across TX — which companies pay providers there.
